Skip to content

The Effect of Orange Blossom Aromatherapy on Migraine Headache

The Effect of Orange Blossom Aromatherapy on Migraine Headache

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241111063670N1
Enrollment
10
Registered
2024-11-28
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Effect of Orange Blossom Aromatherapy on Migraine Headache.

Interventions

Intervention 1: Control group: This group will only use common migraine headache treatments (medicines) and at the end of the intervention, the Midas migraine headache index questionnaire will be dist

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Confirmation of the diagnosis of migraine headache with a history of at least 6 months of moderate intensity migraine headache by a neurologist Not having a history of allergies, sensitivity to plant materials and serious problems that cause a delay in the treatment period with Orange Spring. Selection of people with the drug regimen used by a neurologist Being in the age group of 18 to 50 years Being literate in reading and writing Absence of mental disorders such as personality disorder based on self-report and medical records No use of psychoactive drugs and addiction Consent to participate in the study

Exclusion criteria

Exclusion criteria: Unwillingness to continue cooperation Allergy or complications after aromatherapy

Design outcomes

Primary

MeasureTime frame
Repetition of migraine headaches in the Midas Migraine Headache Indicators Questionnaire. Timepoint: The number of days during the past 2 months that people did not show up at work or social and family activities or did not perform well due to migraine headaches. The Midas Migraine Headache Index Questionnaire will be completed before the start of the intervention and before each aromatherapy session as a checklist at the end of each week and 48 hours after the last treatment period (4 weeks) after the end of the treatment period between the two intervention and control groups. Method of measurement: Midas Migraine Headache Indicators.;Migraine headache duration in the MIDAS migraine headache index questionnaire. Timepoint: The number of days during the past 2 months that people did not show up at work or social and family activities or did not perform well due to migraine headaches. The Midas Migraine Headache Index Questionnaire will be completed before the start of the intervention and before each aromatherapy session as a checklist at the end of each week and 48 hours after the last treatment period (4 weeks) after the end of the treatment period between the two intervention and control groups. Method of measurement: Midas Migraine Headache Indicators.;Migraine headache severity in the Midas Migraine Headache Indicators Questionnaire. Timepoint: The number of days during the past 2 months that people did not show up at work or social and family activities or did not perform well due to migraine headaches. The Midas Migraine Headache Index Questionnaire will be completed before the start of the intervention and before each aromatherapy session as a checklist at the end of each week and 48 hours after the last treatment period (4 weeks) after the end of the treatment period between the two intervention and control groups. Method of measurement: Midas Migraine Headache Indicators.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe ebrahimi Jamnani

Gonabad University of Medical Sciences

ebrahimijamanielahe@gmail.com+98 11 3472 5597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026